Model Organisms in Drug Discovery
Model Organisms in Drug Discovery
Model Organisms in Drug Discovery
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
280 INDEX<br />
bupropion 92<br />
busulfan 143<br />
bystander genes 53<br />
C-C chemok<strong>in</strong>e receptor 2 (CCR2) 263<br />
c-cbl 53<br />
CA-repeats 195, 196<br />
Cactus 172, 173<br />
Caenorhabditis elegans 5, 41–79<br />
assay design 64–6<br />
assay development 66–8<br />
assay validation 69<br />
BMS AG6B 163, 165<br />
conservation 43, 44–5, 50<br />
depression 48–50<br />
disease model 50, 51<br />
dr<strong>in</strong>k<strong>in</strong>g assay 52, 56, 66–7, 69, 71<br />
drug discovery 42–5, 72–3<br />
electrophysiology 65–6<br />
expression profil<strong>in</strong>g 58–9, 175<br />
functional assay 50, 52<br />
gene expression topomap 58–9<br />
gene knock-outs 57–8<br />
gene mapp<strong>in</strong>g us<strong>in</strong>g SNPs 55–6<br />
genetic screens 52–3, 252<br />
genome annotation 60<br />
genomics 43–4<br />
high-throughput screen<strong>in</strong>g 64<br />
hits 70–2, 73<br />
image acquisition 67–8<br />
lead discovery 61–73<br />
mechanism of action studies 53–5,<br />
156–9, 161–2<br />
prote<strong>in</strong> <strong>in</strong>teraction mapp<strong>in</strong>g 59<br />
RNAi 56–7, 170–1<br />
screen<strong>in</strong>g platform 69–70<br />
seroton<strong>in</strong> signal<strong>in</strong>g 48–9, 50<br />
target identification 60–1<br />
target validation 45–7, 60–1<br />
yeast homologs 12<br />
caffe<strong>in</strong>e 157, 158<br />
calc<strong>in</strong>eur<strong>in</strong> 16<br />
calc<strong>in</strong>eur<strong>in</strong> A 264, 265<br />
calmodul<strong>in</strong> 31<br />
calnex<strong>in</strong> 1 18<br />
camptothec<strong>in</strong> 14, 155<br />
cancer 157–9, 143<br />
arachidonic acid 214<br />
<strong>in</strong>sul<strong>in</strong> pathway 127<br />
lipid metabolism 204<br />
p53 139<br />
Ras pathway 124–6, 158–9<br />
WNT pathway 122–3, 135<br />
see also anticancer drugs<br />
capsaic<strong>in</strong> 158<br />
carbachol 158<br />
cardiology 262–3<br />
caspases 13<br />
cataracts 238<br />
b-caten<strong>in</strong> 122<br />
catheps<strong>in</strong> K 253<br />
cdk4-specific antagonists 13<br />
cDNA microarrays 58, 175<br />
cdp2 261<br />
Cecrop<strong>in</strong>s 172, 173<br />
cell-based assays 94–5<br />
cell culture, Drosophila 109<br />
cell cycle 29<br />
cell growth <strong>in</strong>hibition 144<br />
cell proliferation 271<br />
Cellzome 31<br />
central nervous system 45<br />
chemical descriptors 63<br />
chemical genetics 6, 53–4, 98, 141–5,<br />
170–2<br />
chemical modifier screen 96–7<br />
chemical mutagens 103, 128, 129–30, 188,<br />
228–35<br />
chico 127<br />
chit<strong>in</strong>ase assay 67<br />
Chk1 20<br />
cholesterol 13, 204, 208, 209–10, 263<br />
circadian rhythms 94, 242, 269<br />
cleavage-based assay 110<br />
CLN3 12<br />
clock 242, 243<br />
CNK 126<br />
coca<strong>in</strong>e 94, 158<br />
cod<strong>in</strong>g regions 11<br />
cognition 270<br />
colon cancer 122<br />
comb<strong>in</strong>atorial chemistry 63<br />
compact<strong>in</strong> 158<br />
complete blood cell count 264–5<br />
compound<br />
development 154–6<br />
learn<strong>in</strong>g set 69<br />
library 63–4<br />
screens 94–8<br />
compound E 169<br />
Comprehensive Yeast Genome Database 32<br />
computer-assisted tomography 256<br />
congestive heart failure 55<br />
conservation 12–13, 43, 44–5, 50, 82–5,<br />
119–27, 186–7, 216<br />
contractile prote<strong>in</strong>s 205<br />
COPAS TM 68<br />
corticotrop<strong>in</strong>-releas<strong>in</strong>g hormones 48<br />
COX <strong>in</strong>hibitors 156, 214, 216<br />
COX-1 and COX-2 212, 214–17, 268